Eurofins MWG Operon, Genomatix Software partner to offer next-gen sequencing solutions

NewsGuard 100/100 Score

Exclusive worldwide cooperation in next-gen sequencing solutions provides full service for customers

Eurofins MWG Operon, an expert in next generation sequencing (NGS) and Genomatix Software GmbH, a leading company in complex analysis and interpretation of such NGS data, announce their decision to combine their expertise and join forces to offer state-of-the art solutions for comprehensive genome analysis and re-sequencing project services.

"We are pleased to cooperate with a partner offering such a high level of expertise in understanding and interpretation of complex biological processes. The special know-how of Genomatix with its rich proprietary data background will have an enormous impact on our service offerings to our customers and will add a further layer of quality to strengthen our position as the leading provider for next generation sequencing services" says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services.

Klaus May, Chief Business Officer of Genomatix, says: "Eurofins MWG Operon is an outstanding quality and service oriented company with friendly, bright and competent people. I am highly satisfied about this partnership, which represents the first one-stop-shop for complete project services, from experimental planning, wet-lab work and data analysis, to data interpretation and deep biological understanding. Together, we offer our customers cutting edge science and technology without the need for them to make major investments in equipment, infrastructure and manpower."

Both partners have already successfully worked together to gain several significant projects where applicative know-how and powerful bioinformatic capabilities have been key for effective project consulting and execution.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Exploring instruments for assay development and optimization